期刊文献+

连续硬膜外腔阻滞对带状疱疹后遗神经痛的疗效观察 被引量:3

Epidural block in the treatment of postherpetic neuralgia
下载PDF
导出
摘要 目的比较两种治疗方法对带状疱疹后遗神经痛的治疗效果。方法选择带状疱疹后遗神经痛的患者64例,随机分两组,神经阻滞治疗组(A组,n=32)与连续硬膜外腔阻滞治疗组(B组,n=32),连续治疗3-4周。使用药物:B组0.4%-0.8%的盐酸利多卡因+地塞米松2mg+0.9%生理盐水共250ml,流速为5ml/h。A组0.4%-0.8%的盐酸利多卡因+地塞米松2mg+0.9%生理盐水共20ml,1次/3d,连续治疗3-4周。采用视觉模拟评分法(VAS法),分别测评治疗前、硬膜外镇痛、神经外镇痛、神经阻滞结束后及治疗结束后6个月的VAS评分、伴随症状的改善情况以及并发症,从而评估两种方法的疗效和安全性。结果治疗结束时及治疗后6个月时,两组VAS评分均较术前显著降低(P<0.05);两组间VAS评分比较,治疗结束时及治疗后6个月时B组较A组显著降低(P<0.05)。结论神经阻滞、连续硬膜外阻滞对带状疱疹后遗神经痛有明显缓解作用,连续硬膜外阻滞对带状疱疹后遗神经痛的治疗效果更佳。 Objective To compare the therapeutic effects of nerve block and continuously injected into epidural space in the treatment of postherpetic neuralgia.Methods 64 patients (31 males and 33 females) with postherpetic neuralgia were randomly dived into intermittent nerve block group (32 cases) and continous epidural space group(32cases).Mixed liquor of 0.4%-0.8% lidocaine hydrochloride,dexmethasone 2mg and 0.9% NS (total volume 250 ml) had been infusioned continuously into epidural space at the rate of 5ml/h for continuous 3-4 weeks in epidural space group,and mixed liquor of 0.4%-0.8% lidocaine hydrochloride,dexamethasone 2mg and 0.9% NS (total volume 20ml) had been used once in four days for continuous 3-4 weeks in nerve block group.VAS evaluation,patients subjective evaluation were taken and side effects were observed before and after therapy,and six months after therapy.Results Compared with pretreatment,the value of VAS decreased significantly when leaving hospital and six months after therapy in each group (P0.01);compared with nerve block group,the value of VAS decreased significantly when the patients left hospital and six months after therapy in epidural space group (P0.05).Conclusion Epidural block in a row has a significant pain relief effect on postherpetic neuralgia.
作者 杨杰 沈永波
出处 《海南医学》 CAS 2010年第10期49-50,共2页 Hainan Medical Journal
关键词 神经阻滞 连续硬膜外腔镇痛 带状疱疹后遗神经痛 Nerve block Postherpetic neuralgia Epidural
  • 相关文献

参考文献6

二级参考文献15

  • 1王韵.带状疱疹痛与带状疱疹后神经痛[J].中国疼痛医学杂志,1996,2(4):237-241. 被引量:25
  • 2严相默主编.临床疼痛学.第一版.延吉:延边人民出版社,1996,83
  • 3Weller TH. Varicella and herpes zoster: changing concepts of the natural history, control, and importance of a not-so -benign virus. N. Engl, 1983.
  • 4Weller TH. Varicella: historical perspective and clinical overview. J Infect Dis, 1986, 174: S306-S309.
  • 5Davis MM. Successes and remaining challenges after 10 years of varicelia vaccination in the USA. Expert Rev Vaccines, 2006, 5: 295 - 302.
  • 6Fernando de Ory. European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus. J Clin Virol, 2006, 36: 111-118.
  • 7Sanerbrei A. lmmunofluoreseenee test for sensitive detedtion of varicella - zoster virus - speeific IgG : an alternative to fluorescent antibody to membrane antigen test. J Virol Methods, 2004, 119: 25 - 30.
  • 8Keller PM. Purification of individual varicella - zoster virus glycoproteins gp Ⅰ, gp Ⅱ, and gp Ⅲ, and their use in ELISA for detection of VZV glycoprotein - specific antibodies. Elsevier Science Publishers BV (Biomedical Division), 1986.
  • 9Edward H. Sensitive Enzyme - Linked immunosorbent assay for antibody to varlcella - zoster virus using purified VZV glyeoprotein antigen. J Med Virol, 1990, 32:189 - 193.
  • 10Ampofo K. Persistence of Immunity to live attenuated varicella vacine in healthy adults. CID, 2002, 34:774-779.

共引文献19

同被引文献49

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部